AbCellera (ABCL) Stock
NASDAQ · ABCL
12.63
Fundamentals
Market cap
$4.09B
Price / Earnings ratio
-23.7x
Price / Sales ratio
59.0x
Price / Book ratio
4.4x
Return on assets
-0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About AbCellera
AbCellera grew out of the idea that single-cell microfluidics and next-generation technologies can radically change how we discover drugs. But this isn’t just about having advanced technology. It comes from building a world-class group of innovators. Our multidisciplinary team of cell biologists, biochemists, engineers, data scientists, machine learning experts, and business professionals is working on some of the toughest areas of disease. We push the limits of antibody discovery to help partners tackle the world’s most urgent medical challenges.
SectorHealthcare
IndustryBiotechnology
Employees562
CEODr. Carl L.G. Hansen Ph.D.
IPO DateDec 11, 2020
HeadquartersVancouver, BC
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Carl L.G. Hansen Ph.D. | CEO, President & Chairperson | 1975 |
| Mr. Andrew Booth M.B.A. | Chief Financial Officer | 1974 |
| Dr. Veronique Lecault Ph.D. | CTO & Director | 1985 |
| Mr. Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer | 1970 |
| Mr. Andrew Knowles M.Sc. | Vice President of Operations | — |
| Marcie Thiessen CPA, CGA | Senior Director of Finance & Accounting | — |
| Mr. Martin Hogan M.Sc. | Senior Director of Strategic Finance & IR | — |
| Ms. Tiffany Chiu B.Sc., Ph.D. | Vice President of Communications | — |
| Caitlin Webster CIPD, M.Sc. | Director of Talent Development | — |
| Mr. Murray McCutcheon Ph.D. | Senior Vice President of Partnering | — |
Fundamentals
Valuation
Market cap$4.09B
Price-to-sales ratio58.98
Price-to-book value4.36
Price-earnings ratio-23.70
Return on Equity-15.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.54
Income Statement
Average volume5,250,394
EBITDA$-156.47M
1 year high (52w)$13.18
1 year low (52w)$2.75
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



